109 related articles for article (PubMed ID: 38788058)
21. Oral contraceptives and risk of breast cancer.
Paul C; Skegg DC; Spears GF
Int J Cancer; 1990 Sep; 46(3):366-73. PubMed ID: 2394503
[TBL] [Abstract][Full Text] [Related]
22. Hormonal contraception and risk of breast cancer: a critical look.
Barriga P; Vanhauwaert P; Porcile A
Gynecol Endocrinol; 2019 Jun; 35(6):460-462. PubMed ID: 30806523
[TBL] [Abstract][Full Text] [Related]
23. Contraceptive safety among women with cystic fibrosis: a systematic review.
Whiteman MK; Oduyebo T; Zapata LB; Walker S; Curtis KM
Contraception; 2016 Dec; 94(6):621-629. PubMed ID: 27287694
[TBL] [Abstract][Full Text] [Related]
24. Oral contraceptive use and breast cancer in Indonesia.
Bustan MN; Coker AL; Addy CL; Macera CA; Greene F; Sampoerno D
Contraception; 1993 Mar; 47(3):241-9. PubMed ID: 8462315
[TBL] [Abstract][Full Text] [Related]
25. Health outcomes associated with use of hormonal contraception: breast cancer.
Schneyer R; Lerma K
Curr Opin Obstet Gynecol; 2018 Dec; 30(6):414-418. PubMed ID: 30239373
[TBL] [Abstract][Full Text] [Related]
26. Association between contemporary hormonal contraception and ovarian cancer in women of reproductive age in Denmark: prospective, nationwide cohort study.
Iversen L; Fielding S; Lidegaard Ø; Mørch LS; Skovlund CW; Hannaford PC
BMJ; 2018 Sep; 362():k3609. PubMed ID: 30257920
[TBL] [Abstract][Full Text] [Related]
27. Combined hormonal versus nonhormonal versus progestin-only contraception in lactation.
Lopez LM; Grey TW; Stuebe AM; Chen M; Truitt ST; Gallo MF
Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD003988. PubMed ID: 25793657
[TBL] [Abstract][Full Text] [Related]
28. Oral contraceptive use and risk of breast, cervical, colorectal, and endometrial cancers: a systematic review.
Gierisch JM; Coeytaux RR; Urrutia RP; Havrilesky LJ; Moorman PG; Lowery WJ; Dinan M; McBroom AJ; Hasselblad V; Sanders GD; Myers ER
Cancer Epidemiol Biomarkers Prev; 2013 Nov; 22(11):1931-43. PubMed ID: 24014598
[TBL] [Abstract][Full Text] [Related]
29. Changes in mammographic densities induced by a hormonal contraceptive designed to reduce breast cancer risk.
Spicer DV; Ursin G; Parisky YR; Pearce JG; Shoupe D; Pike A; Pike MC
J Natl Cancer Inst; 1994 Mar; 86(6):431-6. PubMed ID: 8120917
[TBL] [Abstract][Full Text] [Related]
30. Strategies to improve adherence and continuation of shorter-term hormonal methods of contraception.
Mack N; Crawford TJ; Guise JM; Chen M; Grey TW; Feldblum PJ; Stockton LL; Gallo MF
Cochrane Database Syst Rev; 2019 Apr; 4(4):CD004317. PubMed ID: 31013349
[TBL] [Abstract][Full Text] [Related]
31. Contraceptives and cancer risks in BRCA1/2 pathogenic variant carriers: a systematic review and meta-analysis.
van Bommel MHD; IntHout J; Veldmate G; Kets CM; de Hullu JA; van Altena AM; Harmsen MG
Hum Reprod Update; 2023 Mar; 29(2):197-217. PubMed ID: 36383189
[TBL] [Abstract][Full Text] [Related]
32. Combined hormonal contraceptive use among breastfeeding women: an updated systematic review.
Tepper NK; Phillips SJ; Kapp N; Gaffield ME; Curtis KM
Contraception; 2016 Sep; 94(3):262-74. PubMed ID: 26002804
[TBL] [Abstract][Full Text] [Related]
33. Hormonal contraception and risk for cognitive impairment or Alzheimer's disease and related dementias in young women: a scoping review of the evidence.
Gregory S; Booi L; Jenkins N; Bridgeman K; Muniz-Terrera G; Farina FR
Front Glob Womens Health; 2023; 4():1289096. PubMed ID: 38025979
[TBL] [Abstract][Full Text] [Related]
34. Hormones and breast cancer.
Wile AG; DiSaia PJ
Am J Surg; 1989 Apr; 157(4):438-42. PubMed ID: 2648885
[TBL] [Abstract][Full Text] [Related]
35. Mortality among oral contraceptive users: 20 year follow up of women in a cohort study.
Vessey MP; Villard-Mackintosh L; McPherson K; Yeates D
BMJ; 1989 Dec; 299(6714):1487-91. PubMed ID: 2514858
[TBL] [Abstract][Full Text] [Related]
36. Canadian Contraception Consensus (Part 3 of 4): Chapter 7--Intrauterine Contraception.
Black A; Guilbert E; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman W; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; Mansouri S
J Obstet Gynaecol Can; 2016 Feb; 38(2):182-222. PubMed ID: 27032746
[TBL] [Abstract][Full Text] [Related]
37. Oral contraceptives as related to cancer and benign lesions of the breast.
Fasal E; Paffenbarger RS
J Natl Cancer Inst; 1975 Oct; 55(4):767-73. PubMed ID: 1185801
[TBL] [Abstract][Full Text] [Related]
38. Impact of contraception on gynecologic cancers.
Herbst AL; Berek JS
Am J Obstet Gynecol; 1993 Jun; 168(6 Pt 2):1980-5. PubMed ID: 8512041
[TBL] [Abstract][Full Text] [Related]
39. Association of Hormonal Contraception with Meningioma Location in Indonesian Patients.
Malueka RG; Hartanto RA; Setyawan NH; Fauzi DNF; Damarjati KR; Rismawan A; Septianastiti MA; Wicaksono AS; Dananjoyo K; Basuki E; Asmedi A; Dwianingsih EK
Asian Pac J Cancer Prev; 2022 Mar; 23(3):1047-1051. PubMed ID: 35345379
[TBL] [Abstract][Full Text] [Related]
40. Oral Contraceptive and Breast Cancer Risks: a Case Control Study in Six Referral Hospitals in Indonesia.
Wahidin M; Djuwita R; Adisasmita A
Asian Pac J Cancer Prev; 2018 Aug; 19(8):2199-2203. PubMed ID: 30139225
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
